Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 12, 2024

BUY
$22.97 - $30.58 $97,415 - $129,689
4,241 New
4,241 $116,000
Q1 2023

Apr 28, 2023

BUY
$30.21 - $48.1 $501,606 - $798,652
16,604 Added 86.47%
35,807 $1.19 Million
Q4 2022

Feb 02, 2023

SELL
$22.28 - $38.71 $223,980 - $389,151
-10,053 Reduced 34.36%
19,203 $590,000
Q3 2022

Oct 31, 2022

SELL
$34.2 - $51.69 $506,365 - $765,322
-14,806 Reduced 33.6%
29,256 $1 Million
Q2 2022

Jul 29, 2022

BUY
$23.14 - $49.68 $850,580 - $1.83 Million
36,758 Added 503.26%
44,062 $1.53 Million
Q1 2022

Apr 29, 2022

SELL
$27.77 - $64.4 $670,923 - $1.56 Million
-24,160 Reduced 76.79%
7,304 $321,000
Q4 2021

Feb 07, 2022

SELL
$54.9 - $105.21 $713,700 - $1.37 Million
-13,000 Reduced 29.24%
31,464 $1.98 Million
Q3 2021

Nov 01, 2021

BUY
$105.0 - $178.37 $330,960 - $562,222
3,152 Added 7.63%
44,464 $4.69 Million
Q2 2021

Aug 12, 2021

BUY
$125.11 - $180.0 $3.89 Million - $5.6 Million
31,090 Added 304.15%
41,312 $7.31 Million
Q1 2021

May 13, 2021

SELL
$126.27 - $191.71 $3.74 Million - $5.68 Million
-29,641 Reduced 74.36%
10,222 $1.36 Million
Q4 2020

Feb 04, 2021

BUY
$81.94 - $135.34 $1.53 Million - $2.52 Million
18,629 Added 87.73%
39,863 $5.4 Million
Q3 2020

Nov 09, 2020

BUY
$73.3 - $89.48 $611,102 - $745,994
8,337 Added 64.64%
21,234 $1.77 Million
Q2 2020

Jul 20, 2020

BUY
$48.82 - $82.53 $401,105 - $678,066
8,216 Added 175.52%
12,897 $1.06 Million
Q1 2020

Apr 30, 2020

BUY
$39.1 - $62.9 $183,027 - $294,434
4,681 New
4,681 $241,000
Q2 2018

Aug 07, 2018

SELL
$18.0 - $25.01 $693,936 - $964,185
-38,552 Closed
0 $0
Q1 2018

May 03, 2018

BUY
$20.05 - $26.96 $7,939 - $10,676
396 Added 1.04%
38,552 $823,000
Q4 2017

Jan 24, 2018

SELL
$21.23 - $34.09 $918,176 - $1.47 Million
-43,249 Reduced 53.13%
38,156 $810,000
Q3 2017

Nov 07, 2017

BUY
$27.0 - $31.11 $2.2 Million - $2.53 Million
81,405
81,405 $2.2 Million

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $3.02B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.